• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.29% Nasdaq Down 0.03%

    Achillion Pharmaceuticals, Inc. (ACHN)

    -NasdaqGS
    9.23 Up 0.12(1.32%) May 22, 4:00PM EDT
    Add to Portfolio
    Prev Close:9.11
    Open:9.13
    Bid:8.75 x 500
    Ask:9.70 x 200
    1y Target Est:15.81
    Beta:1.2
    Earnings Date:Aug 5 - Aug 10 (Est.)
    Day's Range:9.05 - 9.27
    52wk Range:2.65 - 16.87
    Volume:4,080,971
    Avg Vol (3m):3,622,060
    Market Cap:1.09B
    P/E (ttm):N/A
    EPS (ttm):-0.71
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    ACHNUp 1.32%1.09B
    GSKDown 0.66%109.30B
    JNJDown 1.04%281.05B
    RHHBYDown 0.94%N/A

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.74
    Quarterly EPS Est (Jun-15) :-0.18
    Mean Recommendation*:2.3
    PEG Ratio (5 yr expected):-0.71

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Achillion Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes anti-infective drug therapies in the United States and internationally. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback